Lido Advisors
ALXO icon

Lido Advisors’s ALX Oncology ALXO Stock Holding History

Lido Advisors’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18.4K Hold
13,220
– – ﹤0.01% 2035
2026
Q2 		$27.4K Hold
13,220
– – ﹤0.01% 2100
2026
Q1 		$26.5K Hold
13,220
– – ﹤0.01% 1922
2025
Q4 		$24.2K Hold
13,220
– – ﹤0.01% 1911
2025
Q3 		$24.2K Hold
13,220
– – ﹤0.01% 1814
2025
Q2 		$5.49K Hold
13,220
– – ﹤0.01% 1651
2025
Q1 		$8.24K Hold
13,220
– – ﹤0.01% 1501
2024
Q4 		$22.1K Buy
+13,220
New +$20.3K ﹤0.01% 1484

Other funds holding ALXO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
IEQ Capital
IEQ Capital Foster City, California $23.5B AUM 29.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Lido Advisors's ALXO Position: Q3 2026 in Review

Lido Advisors held its ALX Oncology (ALXO) position steady in Q3 2026 at 13,220 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2035.

Lido Advisors first reported a position in ALXO in Q4 2024 and has held it in 8 quarters since. The position peaked at $27.4K in Q2 2026. 36 funds tracked by Wall St. Rank hold ALXO as of Q3 2026.

  • Lido Advisors held 13,220 shares of ALX Oncology worth $18.4K as of Q3 2026.
  • Lido Advisors left its ALX Oncology share count unchanged in Q3 2026.
  • ALX Oncology made up ﹤0.01% of Lido Advisors's portfolio in Q3 2026, its #2035 holding.
  • Lido Advisors first reported a position in ALX Oncology in Q4 2024 and has held it in 8 quarters since.
  • Lido Advisors's ALX Oncology position peaked at $27.4K in Q2 2026.
  • 36 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2026.

Based on Lido Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.